CIK: 1871470 - Address: 355 Alhambra Circle, Suite 801, Coral Gables, FL 33134
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
12/31/24 16:30
12/27/24
CPRXCatalyst Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsHarper MollyFLDM.d00.0001943D
12/11/24 17:00
12/9/24
CPRXCatalyst Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsHarper MollyFLDM.d00.0001New1D
11/29/24 20:09
11/27/24
CPRXCatalyst Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsHarper MollyFLDM.d1015.780180D
11/29/24 20:09
11/27/24
CPRXCatalyst Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsHarper MollyFLDS.d-38522.000-18-1000D
6/5/24 17:00
6/3/24
CPRXCatalyst Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsHarper MollyFLDS-8716.300-5-1000D
2/16/24 17:00
2/15/24
CPRXCatalyst Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsHarper MollyFLDM.d00.00043005D
12/29/23 17:00
12/27/23
CPRXCatalyst Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsHarper MollyFLDM.d00.0001New1D
12/19/23 17:00
12/15/23
CPRXCatalyst Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsHarper MollyFLDS.d-20114.390-14-1000D
12/19/23 17:00
12/15/23
CPRXCatalyst Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsHarper MollyFLDM.d585.780100D
2/17/23 17:01
2/15/23
CPRXCatalyst Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsHarper MollyFLDM.d00.0004New4D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact